Novorapid 100 Unit

NOVORAPID 100 Unit is a rapid-acting insulin solution used to manage blood glucose levels in diabetes. This subcutaneous injection, manufactured by Novo Nordisk Canada Inc., helps control blood sugar spikes after meals.

NOVORAPID 100 Unit is primarily used for the management of diabetes. It is designed to be taken before meals to help control blood sugar levels, particularly after eating. This rapid-acting insulin solution is often prescribed for individuals who require precise blood glucose management. What is NOVORAPID used for? It is commonly used to prevent hyperglycemia (high blood sugar) in people with diabetes.

NOVORAPID 100 Unit works by helping the body absorb glucose from the bloodstream, which can lead to lower blood sugar levels. Common effects may include mild injection site reactions, such as redness or itching. Some users may also experience hypoglycemia (low blood sugar) if the dosage is not carefully managed.

It is important to store NOVORAPID 100 Unit properly to maintain its effectiveness. Keep it refrigerated and protect it from light and heat. Always follow the storage instructions provided by the manufacturer. Additionally, monitor blood sugar levels regularly to avoid hypoglycemia or hyperglycemia.

NOVORAPID 100 Unit may interact with other medications, including oral hypoglycemic agents and certain antibiotics. It is also important to be cautious when consuming alcohol, as it can affect blood sugar levels. Always consult a healthcare provider before starting any new medication or supplement.